Clinical trials are a vital component of the healthcare sector, playing a pivotal role in improving patient health outcomes, and pharmaceutical companies allocate significant resources to clinical logistics each year.

The pharmaceutical industry like many others on a global scale, grapples with macroeconomic shifts, post-pandemic challenges, and industry-specific developments that impose obstacles on supply chain teams. These challenges intensify the need for enhanced efficiency, optimization, and visibility throughout clinical trials.

BS3 provides clinical logistics solutions to pharmaceutical companies.  We deliver compliant expertise that optimize clinical supply chains, expand their reach, and consolidate the network through a single point of contact, and secure online portal.

Clinical trials entail intricate and lengthy processes where retaining and engaging patient involvement, is paramount to success.  Partnering with a logistics specialist that excels in reaching these patients and supporting their sustained participation is crucial to patient outcomes.

Some of the patient challenges effecting retention are:

  • Location related challenges, with many patients residing in remote areas or lacking convenient access to investigator sites.
  • Mobility limitations, poor health, or financial constraints further hinder patient retention.

In these cases, a patient direct delivery solution proves pivotal, delivering direct to patients in their homes. This approach has gained prominence in recent years and played a vital role in minimizing dropouts and expediting product launches.

The pharmaceutical industry faces escalating costs and tighter budgets, heightening the importance of cost efficiency.

Simultaneously, there is a growing recognition of logistics as a specialized and professional function with the potential to drive overall cost and process improvements.

While each clinical trial possesses its unique characteristics, the processes involved can be standardized. Leveraging expertise on a local level presents substantial benefits, to both the patient and pharmaceutical company.  This allows pharmaceutical companies to scale their operations as needed, alleviates logistical concerns, and allows them to concentrate fully on the ultimate objective of improving patient outcomes.